RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kim Finley to Drug Discovery

Back to Details
This is a "connection" page, showing publications Kim Finley has written about Drug Discovery.
Kim Finley
Connection Strength
0.374
Drug Discovery
  1. Liang Z, Candib A, Soriano-Castell D, Fischer W, Finley K, Maher P. Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders. Redox Biol. 2024 Jun; 72:103138.
    View in: PubMed
    Score: 0.221
  2. Schubert D, Currais A, Goldberg J, Finley K, Petrascheck M, Maher P. Geroneuroprotectors: Effective Geroprotectors for the Brain. Trends Pharmacol Sci. 2018 12; 39(12):1004-1007.
    View in: PubMed
    Score: 0.153
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support